Short Interest in CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Grows By 40.1%

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) saw a significant growth in short interest during the month of January. As of January 30th, there was short interest totaling 3,944 shares, a growth of 40.1% from the January 15th total of 2,816 shares. Based on an average trading volume of 5,106 shares, the short-interest ratio is presently 0.8 days. Based on an average trading volume of 5,106 shares, the short-interest ratio is presently 0.8 days.

CSPC Pharmaceutical Group Stock Performance

OTCMKTS CSPCY opened at C$5.18 on Friday. The stock’s 50 day simple moving average is C$4.62 and its 200 day simple moving average is C$4.67. CSPC Pharmaceutical Group has a one year low of C$2.31 and a one year high of C$5.83.

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.

The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.